Australia Patent: Medicinal Bioconvergence Research Center Files Application for 'Pharmaceutical composition comprising antibody binding specifically to lysyl-tRNA synthetase N-terminus as effective ingredient for preventing or treating immune cell migrat

Press/Media: Press / Media

Period2020 May 3

Media coverage

1

Media coverage

  • TitleAustralia Patent: Medicinal Bioconvergence Research Center Files Application for 'Pharmaceutical composition comprising antibody binding specifically to lysyl-tRNA synthetase N-terminus as effective ingredient for preventing or treating immune cell migrat
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date20/5/3
    PersonsSunghoon Kim